Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Parsey Merdad, Directeur Médical. Director active across 4 companies, notably Gilead Sciences INC. Aggregated, 36 reports have been recorded. Split: 0 buy · 9 sells. Total volume traded: €2.2m. Activity tracked since 15 August 2021. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Parsey Merdad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
376 shares@ US$56.38050.2% of flowCommon StockSEC:0001127602-23-006763:0
25 of 36 declarations
About Parsey Merdad
Parsey Merdad is Directeur Médical and also serves as Chief Medical Officer at Gilead Sciences, INC. and Gilead Sciences INC, and as Director at Ardelyx, INC. and Sagimet Biosciences Inc. The declarant has 36 filings in total, and across the sampled recent filings, sales total EUR 2,242,294, with a date range from 2021-08-24 to 2026-06-18 and a modal transaction nature of Option exercise.